ondansetron has been researched along with Hypoxia in 2 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kamendi, HW | 2 |
| Cheng, Q | 2 |
| Dergacheva, O | 2 |
| Gorini, C | 2 |
| Jameson, HS | 2 |
| Wang, X | 2 |
| McIntosh, JM | 1 |
| Mendelowitz, D | 2 |
| Frank, JG | 1 |
| Pinol, RA | 1 |
2 other studies available for ondansetron and Hypoxia
| Article | Year |
|---|---|
Abolishment of serotonergic neurotransmission to cardiac vagal neurons during and after hypoxia and hypercapnia with prenatal nicotine exposure.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Animals, Newborn; Conotoxins; Dose | 2009 |
Recruitment of excitatory serotonergic neurotransmission to cardiac vagal neurons in the nucleus ambiguus post hypoxia and hypercapnia.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adenosine Triphosphate; Animals; Animals, Newborn; Drug Intera | 2008 |